Other Information.
−Removed: On August 4, 2021, Bernhard E.
−Removed: Spiess, our Chief Business Officer, notified us of his intention to resign effective December 31, 2021.
−Removed: Until such time, Mr.
−Removed: Spiess is expected to continue to serve in his current role and maintain his current responsibilities.
−Removed: Spiess’s intention to resign is not the result of any disagreement with us.
−Removed: On August 5, 2021, David Kabakoff, Ph.D.
−Removed: resigned from his position as a member of our Board of Directors, including each committee of our Board of Directors on which he was a member, effective immediately.
−Removed: Kabakoff’s resignation was not due to any disagreement with us on any matter related to operations, policies or practices.
Exhibit Number Description of document
5 unchanged sentences
333-232369), as amended, originally filed with the SEC on June 26, 2019.
−Removed: 10.1*+ Consulting Agreement, dated May 7, 2021, by and among the Registrant and Joseph C.
31.1* Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act.
14 unchanged sentences
** Furnished herewith.
−Removed: + Indicates management contract or compensatory plan.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CASTLE BIOSCIENCES, INC.
−Removed: August 9, 2021 By:
+Added: November 8, 2021 By:
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: August 9, 2021 By:
+Added: November 8, 2021 By:
/s/ Frank Stokes
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.